In a murine model of HFD-fed mice receiving chronic subcutaneous hippurate infusion, hippurate was associated with improved glycemic control, improved insulin secretion, reduced liver inflammation, and reduced liver fibrosis (61). This evidence concerns the gene INS and Hepatic fibrosis.